Whitehall, Orkney, United Kingdom In 2006 was created National Institute for Health Research, which is appeared as Corporate Investor. The venture was found in Europe in United Kingdom. The main department of described Corporate Investor is located in the Whitehall.
The typical case for the fund is to invest in rounds with 1 participant. Despite the National Institute for Health Research, startups are often financed by btov Partners, Wellington Partners, Seroba Life Sciences. In the next rounds fund is usually obtained by btov Partners, Wellington Partners, Seroba Life Sciences.
The important activity for fund was in 2015. The fund is constantly included in less than 2 deals per year. Deals in the range of 5 - 10 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 55 percentage points more often commits exit comparing to other organizations.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Quanta.
Related Funds
| Fund Name | Location |
| Ansera Capital Partners | British Columbia, Canada, Vancouver |
| Audix | New Taipei, Taiwan |
| Eastern Pacific Accelerator | Central Region, Singapore, Singapore |
| Edgewood Partners Insurance Center | California, San Francisco, United States |
| Fortunetech Investment Fund | - |
| Guodian Dianli | China, Dalian, Zhejiang |
| Hermann Companies | Arkansas, Paragould, United States |
| JFE Accelerator | New York, New York, United States |
| JOLT | Canada, Ontario, Toronto |
| PineBridge Investments | New York, New York, United States |
| Quantum Financial Holdings | - |
| ShenZhen (SZSE) | China, Guangdong, Shenzhen |
| SQFive Intelligent Oilfield Solutions | Alberta, Calgary, Canada |
| Summit Pharmaceuticals International | Chiyoda, Japan |
| SWS Ventures | Canada, Ontario, Toronto |
| University of Illinois | Champaign, Illinois, United States |
| Weisi Touzi | - |
| Yao Capital | China, Shanghai |
| Zero-Ten | Japan, Tokyo |
| Zhongzhiyixin Konggu | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OCUWELL | $342K | 01 Aug 2022 | Liverpool, Liverpool, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OCUWELL | $342K | 01 Aug 2022 | Liverpool, Liverpool, United Kingdom |
